Association of the HTR2C gene and antipsychotic induced weight gain:: a meta-analysis

被引:88
作者
De Luca, Vincenzo
Mueller, Daniel J.
de Bartolomeis, Andrea
Kennedy, James L.
机构
[1] Univ Toronto, Dept Psychiat, CAMH, Neurogenet Sect, Toronto, ON M5T 1R8, Canada
[2] Univ Naples Federico II, Sect Psychiat, Dept Neurosci, Naples, Italy
关键词
antipsychotics; HTR2C; meta-analysis; pharmacogenetics; weight gain;
D O I
10.1017/S1461145707007547
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The 5-HT2C receptor has been hypothesized to represent an important modulator in feeding behaviour. Evidence was based on the observation that knock-out mice for the 5-HT2C receptor gene (HTR2C) develop obesity and that many atypical antipsychotics with potent 5-HT2C antagonism may induce weight gain in susceptible individuals. Pharmacogenetic studies focusing mainly on the -759C/T promoter polymorphism (rs3813929) of the X-linked HTR2C gene revealed controversial results. We investigated the association of the HTR2C gene and weight gain using meta-analytical techniques, combining all published data while restricting our analysis to studies investigating the 759C/T. We also investigated whether ancestry (Caucasian vs. Asian) and clinical factors moderated any association. We found evidence for a slight association of -759C/T with weight gain and significance between studies for heterogeneity. Our meta-analysis provides support for the association of HTR2C in weight gain but indicates that firmly establishing the role of pharmacogenetics in clinical psychiatry requires much larger sample sizes that have been hitherto reported.
引用
收藏
页码:697 / 704
页数:8
相关论文
共 35 条
[1]  
Ashby CR, 1996, SYNAPSE, V24, P349, DOI 10.1002/(SICI)1098-2396(199612)24:4<349::AID-SYN5>3.0.CO
[2]  
2-D
[3]   Pharmacogenomics in schizophrenia: the quest for individualized therapy [J].
Basile, VS ;
Masellis, M ;
Potkin, SG ;
Kennedy, JL .
HUMAN MOLECULAR GENETICS, 2002, 11 (20) :2517-2530
[4]   -759C/T genetic variation of 5HT2C receptor and clozapine-induced weight gain [J].
Basile, VS ;
Masellis, M ;
De Luca, V ;
Meltzer, HY ;
Kennedy, JL .
LANCET, 2002, 360 (9347) :1790-1791
[5]  
Basile VS, 2001, J CLIN PSYCHIAT, V62, P45
[6]  
Blin O, 2001, J CLIN PSYCHIAT, V62, P11
[7]   Serotonin receptor 2C (HTR2C) and schizophrenia:: Examination of possible medication and genetic influences on expression levels [J].
Castensson, A ;
Åberg, K ;
McCarthy, S ;
Saetre, P ;
Andersson, B ;
Jazin, E .
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2005, 134B (01) :84-89
[8]   Decrease of serotonin receptor 2C in schizophrenia brains identified by high-resolution mRNA expression analysis [J].
Castensson, A ;
Emilsson, L ;
Sundberg, R ;
Jazin, E .
BIOLOGICAL PSYCHIATRY, 2003, 54 (11) :1212-1221
[9]   Pharmacogenetics in psychosis [J].
Collier, DA .
DRUG NEWS & PERSPECTIVES, 2003, 16 (03) :159-165
[10]   Pharmacogenetics of antipsychotic-induced weight gain [J].
Correll, CU ;
Malhotra, AK .
PSYCHOPHARMACOLOGY, 2004, 174 (04) :477-489